The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review

B-cell non-Hodgkin lymphoma (B-NHL) is a lymphoid malignancy derived from B-cells that remains difficult to treat. Moreover, relapses and refractory cases are common. Abnormalities in epigenetic mechanisms, such as imbalanced histone acetylation affecting certain genes, contribute to relapses and re...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hastono Ridwansyah, Indra Wijaya, Muhammad Hasan Bashari, Achmad Hussein Sundawa Kartamihardja, Bethy Suryawathy Hernowo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-09-01
coleção:	Biomolecules & Biomedicine
Assuntos:	Chidamide tucidinostat histone deacetylase (HDAC) histone deacetylase inhibitors non-Hodgkin lymphoma (NHL)
Acesso em linha:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/8791
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!